May 13, 2010 — Eltrombopag (Promacta; GlaxoSmithKline) has been linked to an increased risk for portal venous thrombosis in patients with thrombocytopenia due to chronic liver disease, and the company ...
APPLICATION of the technics of hepatic-vein catheterization and percutaneous splenic puncture, with appropriate blood-flow and pressure measurements and radiologic visualization of the portal bed, has ...
Veins are a type of blood vessel that return deoxygenated blood from your organs back to your heart. These are different from your arteries, which deliver oxygenated blood from your heart to the rest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback